Aster Capital Management »

Axsome Therapeutics shares owned by Aster Capital Management

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Aster Capital Management from 13F filings

Historical chart of Aster Capital Management investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Aster Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Aster Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9k 37 104.38
2026-03-31 $6.5k 56 116.63

More positions owned by Aster Capital Management

Ishares Tr U.s. Real Es Etf (IYR)
Apple (AAPL)
Microsoft Corporation (MSFT)
Honeywell International (HON)
Coca-Cola Company (KO)
Spdr Series Trust St Str Sp Regbnk (KRE)
James Hardie Inds Ord Shs (JHX)
Spdr Series Trust Sp O&g Expl Pro (XOP)
Space Exploration Techn Cor P Class A Com Stk (SPCX)
Honeywell Aerospace (HONA)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
FedEx Corporation (FDX)
Amazon (AMZN)
Meta Platforms Cl A (META)

View all positions for Aster Capital Management

Top funds holding Axsome Therapeutics

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Invesco
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Susquehanna International
Jane Street
Deep Track Capital
Two Sigma Investments
Franklin Resources
Wellington Management Company
D. E. Shaw & Co

View all funds holding Axsome Therapeutics